Dyadic International DYAI
NASDAQ DYAI
$0.49 -0.02 (-3.66%)
As of: Sep 10, 2026 · 3:59 PM EDT

Dyadic International (DYAI) Total Current Liabilities (2017 - 2026)

Dyadic International's (DYAI) quarterly Total Current Liabilities came in at $3.2 million in Q1 2026, up 62.26% year-over-year from $2.0 million in Q1 2025, and down 13.65% quarter-over-quarter from $3.7 million in Q4 2025.

Analysis

Dyadic International (DYAI) Total Current Liabilities (2017 - 2026) Analysis & Trends

Dyadic International has disclosed Total Current Liabilities across 10 years of filings, most recently posting $3.2 million for Q1 2026.

  • In Q1 2026, Total Current Liabilities rose 62.26% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (up 62.26% YoY), while the FY2025 annual figure was $3.7 million, up 50.62% from the prior year.
  • Total Current Liabilities came in at $3.2 million for Q1 2026 at Dyadic International, down from $3.7 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $1.8 billion in Q1 2022 to a low of $1.5 million in Q3 2023.
  • Average Total Current Liabilities over 5 years is $109.9 million, with a median of $2.4 million recorded in 2022.
  • Year-over-year, Total Current Liabilities soared 70319.08% in 2022 and sank 99.9% in 2023.
  • Over 5 years, Total Current Liabilities stood at $2.4 million in 2022, then fell by 8.04% to $2.3 million in 2023, then climbed by 8.71% to $2.4 million in 2024, then surged by 50.62% to $3.7 million in 2025, then dropped by 13.65% to $3.2 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $3.2 million in Q1 2026, $3.7 million in Q4 2025, and $4.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 25.50 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 11.02 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 3.94 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 5.53 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.58 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 2.53 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.51 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 3.92 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 283.60 Mn
10 Dyadic International 17.78 Mn 9.82 Mn - 3.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.18 Mn
Dec 31, 2025 3.69 Mn
Sep 30, 2025 4.05 Mn
Jun 30, 2025 3.66 Mn
Mar 31, 2025 1.96 Mn
Dec 31, 2024 2.45 Mn
Sep 30, 2024 2.08 Mn
Jun 30, 2024 1.95 Mn
Mar 31, 2024 2.26 Mn
Dec 31, 2023 2.25 Mn
Sep 30, 2023 1.46 Mn
Jun 30, 2023 2.00 Mn
Mar 31, 2023 1.88 Mn
Dec 31, 2022 2.45 Mn
Sep 30, 2022 2.39 Mn
Jun 30, 2022 3.40 Mn
Mar 31, 2022 1.83 Bn
Dec 31, 2021 2.56 Mn
Sep 30, 2021 1.96 Mn
Jun 30, 2021 3.29 Mn